The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias
September 08, 2022
Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the…
Read More
Top 10 content for the month of August 2022
By Melinda Taschetta-Millane
September 07, 2022
Top 10: A Look at the Hot Topics from August
Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and…
Read More
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population
September 07, 2022
Volta Medical’s AI Based solution for Patients in Atrial Fibrillation Achieves Robust Validation in First Peer-Reviewed Publication
September 7, 2022 —  Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid…
Read More
Graphical abstract During COVID19 total lockdown in 2020 in France, a significant reduction in vascular stiffness, recorded by home smart scales, was observed.© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society o f Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me
September 07, 2022
Strict COVID Lockdowns in France Improved Cardiovascular Health
September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press,…
Read More
Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration
September 07, 2022
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to…
Read More
Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022
September 06, 2022
Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and …
Read More
Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life
September 06, 2022
Study Highlights Lifelong Benefits of Statin Therapy
September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart…
Read More
Smokers have weaker hearts than non-smokers, according to research
September 06, 2022
Smoking is Even More Damaging to the Heart Than Previously Thought
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1…
Read More
Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.
September 06, 2022
Air Pollution is Associated with Heart Attacks in Non-Smokers
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and…
Read More
BOX trial presented in a Hot Line Session at ESC Congress 2022
September 02, 2022
Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac…
Read More
DELIVER trial presented in a Hot Line Session at ESC Congress 2022
September 02, 2022
Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure…
Read More
ADVOR trial presented in a Hot Line Session at ESC Congress 2022
September 02, 2022
Acetazolamide Improves Decongestion in Patients with Acute Decompensated Heart Failure
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in…
Read More
DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022
September 02, 2022
Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including …
Read More
DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022
September 02, 2022
Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was…
Read More
Figure: EchoNet-RCT trial design
September 02, 2022
Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by …
Read More
REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022
September 02, 2022
Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure…
Read More
More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22
September 01, 2022
Best of ESC Congress 2022
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective…
Read More
Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.
September 01, 2022
Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in…
Read More
ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022
September 01, 2022
Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial…
Read More
BioIntelliSense's new BioButton for 90-days of continuous wireless temperature and vital signs monitoring on a coin-sized disposable medical device
August 31, 2022
Medtronic Announces Partnership with BioIntelliSense for Exclusive U.S. Distribution of Multi-Parameter Wearable for Continuous Remote Patient Monitoring from in-Hospital to Home 
August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now